chronic
enteropathi
dog
cat
suggest
pathogenesi
similar
peopl
ibd
recent
studi
detect
disbal
express
innat
immun
receptor
socal
tolllik
receptor
tlr
intestin
dog
ibd
similar
seen
peopl
ibd
express
receptor
also
correl
sever
clinic
diseas
dog
ibd
make
like
causal
implic
pathogenesi
addit
disbal
microbiom
socal
dysbiosi
identifi
use
molecular
method
dog
cat
ibd
find
point
toward
pathogenesi
ibd
dog
cat
similar
peopl
even
clinic
manifest
diseas
differ
hope
similar
advanc
regard
diagnost
option
new
therapeut
modal
made
canin
felin
ibd
done
ibd
human
thorough
histori
import
evalu
small
anim
patient
exhibit
sign
intestin
disord
first
differenti
establish
whether
diseas
acut
chronic
diarrhea
vomit
dehydr
weight
loss
lethargi
melena
sign
small
intestin
diseas
diseas
acut
clinic
sign
present
day
howev
clinic
sign
persist
week
intermitt
present
week
diseas
defin
chronic
anim
diarrhea
next
step
determin
whether
small
intestin
larg
intestin
combin
small
larg
intestin
diarrhea
tabl
system
well
clinic
sign
persist
week
addit
workup
requir
establish
diagnosi
chronic
case
common
system
nongastrointestin
problem
caus
sign
therefor
first
diagnost
step
must
direct
exclud
extragastrointestin
caus
diagnosi
chronic
gastrointestin
caus
one
exclus
full
diagnost
workup
need
done
first
rule
known
caus
extragastrointestin
inflamm
workup
commonli
involv
complet
blood
cell
count
serum
biochem
analysi
urinalysi
fecal
analysi
helminth
protozo
parasit
giardia
tritrichomona
cat
test
indic
none
test
abnorm
trypsinlik
immunoreact
exclud
epi
canin
pancreat
lipas
immunoreact
cpli
assess
possibl
pancreat
pancreat
tumor
corticotropin
stimul
test
basal
cortisol
concentr
exclud
hypoadrenocortic
cobalamin
concentr
assess
absorpt
function
distal
small
intestin
total
thyroxin
felvfiv
infect
also
assess
cat
abdomin
ultrasonographi
help
endoscopi
determin
whether
small
andor
larg
intestin
affect
whether
mass
lesion
need
surgic
intervent
result
test
determin
caus
clinic
sign
patient
stabl
ie
normal
appetit
letharg
minim
weight
loss
serum
protein
concentr
normal
intestin
thicken
diagnost
imag
wellconduct
therapeut
trial
elimin
diet
hydrolyz
diet
least
week
perform
respons
wellconduct
dietari
trial
within
week
start
diet
unlik
patient
suffer
foodrespons
diseas
frd
food
allergi
food
intoler
dietari
trial
unsuccess
antimicrobi
metronidazol
mgkg
mouth
twice
day
tylosin
mgkg
mouth
twice
day
week
small
intestin
disord
dog
cat
administ
intestin
biopsi
histopatholog
collect
patient
either
fail
respond
empir
therapi
worsen
clinic
sign
patient
chronic
enteropathi
diagnos
obtain
endoscop
biopsi
long
least
biopsi
small
intestin
taken
fig
rare
case
diagnosi
lymphoma
miss
fullthick
biopsi
obtain
especi
cat
ileum
sampl
decreas
serum
albumin
concentr
describ
neg
prognost
indic
retrospect
prospect
studi
ibd
dog
proteinlos
enteropathi
ple
account
loss
albumin
gut
mucosa
sever
affect
dog
ibd
ple
dog
associ
sever
lymphoplasmacyt
ibd
intestin
lymphoma
rare
primari
lymphangiectasia
one
studi
dog
ibd
dog
hypoalbuminemia
panhypoproteinemia
seven
dog
hypoalbuminemia
euthan
intract
ibd
identifi
decreas
serum
albumin
concentr
major
risk
factor
associ
wors
outcom
anoth
recent
prospect
studi
dog
ibd
dog
initi
present
hypoalbuminemia
dog
panhypoproteinem
sever
hypoalbuminemia
mean
albumin
level
gl
dog
eventu
euthan
howev
must
note
rel
mild
reduct
serum
albumin
gl
previous
associ
increas
risk
refractori
treatment
level
patient
yet
show
clinic
sign
hypoalbuminemia
ascit
peripher
edema
pleural
effus
furthermor
anoth
studi
found
sever
hypoalbuminem
dog
fail
improv
immunosuppress
dose
steroid
success
treat
cyclosporin
find
suggest
earli
aggress
treatment
hypoalbuminem
dog
may
potenti
decreas
mortal
rate
sever
ill
anim
serum
albumin
concentr
also
use
monitor
patient
improv
serum
albumin
concentr
higher
gl
usual
indic
treatment
success
even
clinic
improv
seen
earlier
case
therefor
recommend
evalu
serum
albumin
concentr
everi
week
assess
treatment
taper
discontinu
much
publish
inform
regard
serum
albumin
concentr
cat
chronic
intestin
diseas
ple
clinic
syndrom
exist
cat
clinic
sign
ascit
peripher
edema
usual
occur
cat
hypoalbuminemia
caus
intestin
diseas
addit
hypoalbuminemia
seen
case
usual
mild
cat
ibd
preval
hypoalbuminemia
rang
howev
evid
cat
chronic
intestin
diseas
decreas
serum
albumin
concentr
may
concurr
pancreat
diseas
one
recent
retrospect
studi
cat
ibd
serum
felin
pancreat
lipas
fpli
concentr
mgl
higher
lower
median
serum
albumin
concentr
cat
ibd
normal
fpli
howev
hypoalbuminemia
neg
predictor
surviv
studi
anoth
studi
found
cat
moder
sever
pancreat
significantli
like
hypoalbuminem
healthi
cat
cat
mild
pancreat
therefor
hypoalbuminemia
cat
chronic
intestin
diseas
prompt
clinician
measur
fpli
concentr
andor
perform
abdomin
ultrasonograph
examin
determin
concurr
pancreat
depend
sever
hypoalbuminemia
clinician
approach
treatment
might
alter
serum
cobalamin
concentr
measur
small
anim
patient
chronic
small
intestin
diseas
cobalamin
absorpt
receptormedi
ileum
decreas
serum
cobalamin
concentr
commonli
seen
part
small
intestin
affect
howev
absorpt
cobalamin
also
involv
intrins
factor
dog
cat
produc
primarili
pancrea
reason
small
anim
epi
low
serum
cobalamin
concentr
fig
author
group
shown
recent
serum
cobalamin
also
import
prognosi
dog
chronic
enteropathi
cobalamin
serum
concentr
refer
interv
risk
later
euthanasia
increas
factor
therefor
import
supplement
dog
hypocobalaminemia
undergo
treatment
ibd
risk
euthanasia
revers
cobalamin
supplement
serum
cobalamin
concentr
long
known
import
neg
prognost
factor
cat
chronic
enteropathi
preval
decreas
serum
cobalamin
concentr
cat
chronic
gastrointestin
sign
small
intestin
disord
dog
cat
report
cat
also
report
cobalamin
supplement
improv
clinic
sign
regardless
underli
diagnosi
even
given
sole
treatment
diseas
therefor
recommend
cat
chronic
intestin
diseas
supplement
cobalamin
regardless
whether
specif
caus
diseas
identifi
supplement
cobalamin
given
parenter
subcutan
weekli
inject
least
week
exact
dosag
report
watersolubl
vitamin
overdos
test
recommend
pleas
visit
web
site
texa
gi
laboratori
http
vetmedtamuedugilab
cpli
recent
becom
avail
commerci
test
use
assess
pancreat
dog
howev
cpli
also
elev
dog
chronic
enteropathi
retrospect
studi
dog
ibd
author
group
evalu
clinic
sign
age
serum
lipas
amylas
activ
albumin
cobalamin
concentr
abdomin
ultrasonographi
result
histopatholog
review
intestin
biopsi
manag
ibd
followup
dog
ibd
either
without
concurr
chronic
pancreat
sixteen
dog
increas
cpli
dog
normal
cpli
valu
compar
signific
differ
found
clinic
activ
score
serum
amylas
activ
serum
lipas
activ
serum
absorpt
cobalamin
complex
process
involv
sever
step
cobalamin
releas
food
protein
stomach
immedi
bound
rbinder
protein
b
proxim
small
intestin
cobalaminrbind
complex
cleav
digest
rbinder
pancreat
proteas
c
free
cobalamin
bind
intrins
factor
major
secret
pancrea
cat
dog
cobalaminif
complex
subsequ
absorb
special
receptor
ileum
e
cobalamin
concentr
serum
albumin
concentr
abdomin
ultrasonographi
score
histopatholog
score
ibd
differ
frequenc
steroid
treatment
group
dog
ibd
concurr
elev
cpli
significantli
older
dog
without
elev
cpli
moreov
dog
elev
cpli
higher
risk
poor
followup
score
significantli
like
euthan
followup
data
show
elev
cpli
canin
ibd
may
indic
subset
patient
could
also
chronic
subclin
pancreat
patient
diagnos
ibd
also
elev
cpli
without
overt
imag
evid
acut
pancreat
recommend
discuss
treatment
option
ibd
also
treat
possibl
autoimmun
pancreat
author
anecdot
success
cyclosporin
mgkg
daili
week
case
creactiv
protein
crp
serum
acutephas
protein
elev
mani
differ
diseas
peopl
ibd
sever
calcul
indic
clinic
activ
diseas
incorpor
measur
crp
dog
similar
correl
canin
ibd
activ
index
cibdai
serum
crp
concentr
found
one
larg
studi
dog
crp
elev
dog
cibdai
score
greater
compris
mild
moder
diseas
activ
comparison
normal
dog
crp
decreas
significantli
treatment
author
experi
crp
help
assess
dog
chronic
enteropathi
crp
measur
dog
ibd
treatment
dog
treatment
crp
elev
dog
treatment
correl
cibdai
histolog
score
larg
percentag
dog
ibd
show
elev
crp
interpret
elev
level
also
may
hamper
increas
relat
diseas
ibd
fecal
proteinas
inhibitor
pi
use
test
dog
clinician
suspect
ple
although
clinic
sign
yet
overtli
visibl
pi
plasma
protein
similar
size
albumin
intestin
mucos
barrier
compromis
loss
protein
intestin
lumen
occur
pi
lost
approxim
rate
albumin
unlik
albumin
howev
proteinas
inhibitor
properti
protect
pi
degrad
intestin
proteas
measur
fece
test
recent
valid
dog
prompt
diagnosi
ple
patient
ibd
import
hypoalbuminemia
risk
factor
neg
outcom
caus
treat
aggress
improv
surviv
pi
assay
especi
valuabl
patient
intestin
diseas
concurr
renal
hepat
diseas
patient
measur
fecal
pi
help
assess
portion
protein
loss
attribut
intestin
test
avail
texa
gi
laboratori
ideal
consecut
fresh
fecal
sampl
submit
improv
test
accuraci
mean
fecal
pi
use
test
practition
outsid
north
america
sampl
intestin
biopsi
essenti
step
evalu
small
intestin
disord
exclud
neoplast
caus
confirm
presenc
intestin
small
intestin
disord
dog
cat
inflamm
howev
interpret
intestin
biopsi
difficult
subject
controversi
sever
recent
studi
look
convent
histolog
interpret
intestin
biopsi
correl
clinic
activ
histolog
grade
either
therapi
addit
total
lymphocyt
count
well
number
infiltr
cell
lamina
propria
use
marker
clinic
activ
diseas
differ
cell
count
treatment
find
suggest
type
degre
histolog
infiltr
canin
ibd
may
help
human
medicin
clinic
score
correl
well
histolog
grade
therefor
new
grade
scheme
histolog
interpret
endoscop
obtain
biopsi
dog
cat
ibd
recent
publish
wsava
work
group
find
studi
suggest
microarchitectur
chang
seem
much
import
cellular
infiltr
assess
histolog
sever
howev
limit
inform
well
new
grade
system
correl
clinic
diseas
one
retrospect
studi
interpathologist
variabl
still
high
even
use
pictur
guid
origin
public
addit
concern
paramet
correl
clinic
diseas
presenc
lymphangiectasia
hypoalbuminemia
prospect
studi
warrant
wsava
score
adopt
use
tool
clinician
polymeras
chain
reaction
antigen
receptor
rearrang
parr
amplifi
highli
variabl
tor
bcell
antigen
receptor
gene
use
detect
presenc
clonal
expand
popul
lymphocyt
test
advoc
use
appli
endoscop
sampl
biopsi
diagnosi
intestin
lymphoma
suspect
confirm
convent
histopatholog
studi
royal
veterinari
colleg
author
prospect
evalu
accuraci
parr
diagnosi
intestin
lymphoma
biopsi
obtain
endoscop
dog
comparison
gold
standard
histopatholog
clinic
outcom
determin
followup
inform
least
year
sampl
dog
includ
parr
result
indic
clonal
expans
dog
howev
dog
clinic
healthi
dietari
treatment
year
endoscopi
clearli
lymphoma
data
studi
indic
falseposit
rate
almost
parr
perform
endoscop
biopsi
anoth
recent
studi
confirm
find
show
dog
ibd
parr
result
show
least
one
oligoclon
pattern
dog
immunoglobulin
tcell
receptor
monoclon
pattern
dog
conclus
posit
parr
test
endoscop
biopsi
mean
diagnosi
lymphoma
must
therefor
made
cautious
clinic
situat
clinic
sign
respons
treatment
immunohistochemistri
must
also
taken
account
perinuclear
antineutrophil
cytoplasm
antibodi
panca
use
diagnosi
human
ibd
decad
antibodi
serum
autoantibodi
similar
antinuclear
antibodi
ana
seem
specif
intestin
diseas
ana
panca
detect
immunofluoresc
visual
typic
pattern
perinuclear
stain
first
studi
assess
clinic
use
panca
dog
ibd
sensit
panca
specif
rang
panca
prove
highli
specif
marker
ibd
dog
group
dog
allenspach
chronic
diarrhea
caus
test
dog
ibd
specif
find
agreement
report
human
medicin
show
specif
panca
distinguish
ibd
healthi
control
well
patient
nonibdrel
diarrhea
caus
panca
test
group
dog
frd
compar
panca
dog
steroidrespons
diseas
posit
panca
titer
significantli
associ
frd
panca
assay
might
help
differenti
dog
chronic
diarrhea
caus
frd
ibd
result
posit
foodrespons
chronic
enteropathi
highli
like
howev
result
neg
ibd
exclud
panca
also
may
associ
syndrom
famili
ple
softcoat
wheaten
terrier
scwt
panca
detect
serum
dog
averag
year
onset
clinic
diseas
highli
correl
hypoalbuminemia
test
could
use
screen
test
specif
diseas
scwt
care
must
taken
interpret
posit
panca
test
result
inflammatori
immunemedi
diseas
present
recent
studi
show
mani
dog
variou
vectorborn
diseas
immunemedi
hemolyt
anemia
posit
panca
calprotectin
calprotectin
calciumbind
protein
abund
granul
neutrophil
macrophag
peopl
ibd
serum
fecal
concentr
protein
increas
comparison
healthi
peopl
addit
fecal
concentr
calprotectin
correl
well
clinic
diseas
activ
children
ibd
immunoassay
measur
canin
calprotectin
serum
fecal
sampl
avail
serum
calprotectin
concentr
mgl
higher
sensit
specif
distinguish
dog
idiopath
ibd
healthi
dog
howev
calprotectin
concentr
significantli
correl
clinic
sever
serum
crp
concentr
sever
histopatholog
chang
clinic
use
test
need
evalu
pglycoprotein
pgp
transmembran
protein
function
drugefflux
pump
intestin
epithelium
human
patient
ibd
fail
respond
treatment
glucocorticosteroid
express
high
level
pgp
lamina
propria
lymphocyt
two
research
group
evalu
pgp
express
biopsi
dog
ibd
one
studi
duoden
biopsi
dog
evalu
immunohistochemistri
biopsi
evalu
treatment
prednisolon
dog
dietari
therapi
alon
dog
dog
treat
prednisolon
show
significantli
higher
pgp
express
lamina
propria
lymphocyt
treatment
compar
express
treatment
contrast
group
treat
sole
elimin
diet
show
differ
pgp
score
treatment
moreov
statist
signific
associ
refractori
steroid
treatment
high
pgp
express
found
glucocorticosteroidtr
group
anoth
recent
studi
pgp
express
higher
duoden
epitheli
cell
dog
ibd
compar
healthi
control
dog
howev
differ
pgp
express
colon
epitheli
cell
ibd
control
group
result
indic
epitheli
lamina
propria
lymphocyt
express
pgp
upregul
dog
ibd
even
higher
prednisolon
treatment
small
intestin
disord
dog
cat
addit
high
pgp
express
could
indic
possibl
multidrug
resist
taken
account
manag
dog
fail
steroid
treatment
previous
marker
human
murin
dendrit
cell
dc
cell
express
marker
shown
similar
morpholog
function
characterist
dog
dc
import
determin
outcom
immun
reaction
gut
whether
pathogen
elicit
massiv
immun
respons
whether
commens
induc
toler
specif
subset
induc
dc
decreas
diseas
tissu
peopl
ibd
plausibl
number
dc
intestin
could
use
surrog
marker
inflamm
dog
ibd
one
recent
studi
endoscop
biopsi
duodenum
ileum
colon
obtain
dog
ibd
healthi
dog
express
assess
immunofluoresc
use
canin
monoclon
antibodi
fig
number
cell
duodenum
ileum
colon
dog
ibd
significantli
reduc
comparison
control
signific
neg
correl
number
cell
colon
dog
ibd
clinic
sever
marker
therefor
hold
promis
use
test
assess
histolog
sampl
howev
addit
prospect
studi
need
evalu
clinic
util
test
last
decad
numer
gene
associ
increas
risk
develop
ibd
human
mani
implic
innat
immun
respons
intestin
dog
ibd
may
similar
genet
compon
especi
breed
predispos
certain
form
ibd
boxer
predispos
histiocyt
ulcer
coliti
german
shepherd
dog
gsd
predispos
lymphoplasmacyt
ibd
author
group
recent
perform
mutat
analysi
canin
gene
gsd
ibd
evalu
casecontrol
studi
case
healthi
gsd
control
sever
mutat
found
significantli
associ
increas
risk
develop
ibd
moreov
result
replic
nongsd
breed
mutat
followup
studi
show
peripher
blood
cell
dog
carri
mutat
hyperrespons
flagellin
natur
ligand
find
prove
first
time
genet
mutat
implic
pathogenesi
dog
ibd
function
consequ
protein
level
taken
togeth
find
make
like
mutat
causal
associ
canin
ibd
genet
test
polymorph
current
avail
royal
veterinari
colleg
test
could
becom
import
breeder
practition
futur
howev
like
multifactori
diseas
ibd
dog
genet
mutat
environment
factor
also
play
role
pathogenesi
advent
genomewid
associ
studi
possibl
caus
mutat
identifi
mani
laboratori
test
avail
aid
diagnost
workup
cat
dog
chronic
small
intestin
disord
avail
mani
year
serum
albumin
cobalamin
concentr
well
canin
pancreat
lipas
new
data
show
test
also
may
prognost
indic
anim
chronic
enteropathi
test
rel
recent
becom
avail
practition
serum
crp
fecal
pi
wsava
standard
histopatholog
read
parr
valu
test
need
evalu
everi
clinic
situat
new
test
yet
wide
avail
panca
calprotectin
immunofluoresc
genet
test
may
becom
use
test
futur
